Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity (original) (raw)

• Holmes, R.S. & Vaughan, T.L. Epidemiology and pathogenesis of esophageal cancer. Semin. Radiat. Oncol. 17, 2–9 (2007).
  Article PubMed Google Scholar
• Pohl, H. & Welch, H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J. Natl. Cancer Inst. 97, 142–146 (2005).
  Article PubMed Google Scholar
• Wu, A.H., Wan, P. & Bernstein, L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 12, 721–732 (2001).
  Article CAS PubMed Google Scholar
• Chung, S.M., Kao, J., Hyjek, E. & Chen, Y.T. p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele. Int. J. Oncol. 31, 1351–1355 (2007).
  CAS PubMed Google Scholar
• Hardie, L.J. et al. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations. Cancer Lett. 217, 221–230 (2005).
  Article CAS PubMed Google Scholar
• Choi, Y.W., Heath, E.I., Heitmiller, R., Forastiere, A.A. & Wu, T.T. Mutations in β-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas. Mod. Pathol. 13, 1055–1059 (2000).
  Article CAS PubMed Google Scholar
• Sommerer, F. et al. Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma. Oncogene 23, 554–558 (2004).
  Article CAS PubMed Google Scholar
• Wijnhoven, B.P., de Both, N.J., van Dekken, H., Tilanus, H.W. & Dinjens, W.N. E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus. Br. J. Cancer 80, 1652–1657 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Pühringer-Oppermann, F.A., Stein, H.J. & Sarbia, M. Lack of EGFR gene mutations in exons 19 and 21 in esophageal (Barrett's) adenocarcinomas. Dis. Esophagus 20, 9–11 (2007).
  Article PubMed Google Scholar
• Guo, M., Liu, S. & Lu, F. Gefitinib-sensitizing mutations in esophageal carcinoma. N. Engl. J. Med. 354, 2193–2194 (2006).
  Article CAS PubMed Google Scholar
• Phillips, W.A. et al. Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus. Int. J. Cancer 118, 2644–2646 (2006).
  Article CAS PubMed Google Scholar
• Boonstra, J.J. et al. Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts. Genes Chromosom. Cancer 51, 272–282 (2012).
  Article CAS PubMed Google Scholar
• Agrawal, N. et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2, 899–905 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609–615 (2011).
• Berger, M.F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214–220 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Chapman, M.A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467–472 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213–219 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107–1120 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519–525 (2012).
• Berger, M.F. et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485, 502–506 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Bass, A.J. et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent _VTI1A_-TCF7L2 fusion. Nat. Genet. 43, 964–968 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Orlando, R.C. Mucosal defense in Barrett's esophagus. in Barrett's Esophagus and Esophageal Adenocarcinoma (ed. Sharma, P.) 60–72 (Blackwell Publishing, Oxford, 2006).
• Dulak, A.M. et al. Gastrointestinal adenocarcinomas of the esophagus, stomach and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res. 72, 4383–4393 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).
• Banerji, S . et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405–409 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Barbieri, C.E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685–689 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Farris, A.B. III et al. Clinicopathologic and molecular profiles of microsatellite unstable Barrett esophagus–associated adenocarcinoma. Am. J. Surg. Pathol. 35, 647–655 (2011).
  Article PubMed Google Scholar
• Sanui, T. et al. DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1. Blood 102, 2948–2950 (2003).
  Article CAS PubMed Google Scholar
• Hanawa-Suetsugu, K. et al. Structural basis for mutual relief of the Rac guanine nucleotide exchange factor DOCK2 and its partner ELMO1 from their autoinhibited forms. Proc. Natl. Acad. Sci. USA 109, 3305–3310 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gómez del Pulgar, T., Benitah, S.A., Valeron, P.F., Espina, C. & Lacal, J.C. Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 27, 602–613 (2005).
  Article PubMed CAS Google Scholar
• Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251–263 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kissil, J.L. et al. Requirement for Rac1 in a K-ras–induced lung cancer in the mouse. Cancer Res. 67, 8089–8094 (2007).
  Article CAS PubMed Google Scholar
• Pan, Y. et al. Expression of seven main Rho family members in gastric carcinoma. Biochem. Biophys. Res. Commun. 315, 686–691 (2004).
  Article CAS PubMed Google Scholar
• Sander, E.E. et al. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143, 1385–1398 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Nishihara, H. et al. Non-adherent cell–specific expression of DOCK2, a member of the human CDM-family proteins. Biochim. Biophys. Acta 1452, 179–187 (1999).
  Article CAS PubMed Google Scholar
• Sanz-Moreno, V. et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135, 510–523 (2008).
  Article CAS PubMed Google Scholar
• Jarzynka, M.J. et al. ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res. 67, 7203–7211 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Shrestha, Y. et al. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene 31, 3397–3408 (2012).
  Article CAS PubMed Google Scholar
• Medina, P.P. et al. Frequent BRG1/_SMARCA4_-inactivating mutations in human lung cancer cell lines. Hum. Mutat. 29, 617–622 (2008).
  Article CAS PubMed Google Scholar
• Zang, Z.J. et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat. Genet. 44, 570–574 (2012).
  Article CAS PubMed Google Scholar
• Fujimoto, A. et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet. 44, 760–764 (2012).
  Article CAS PubMed Google Scholar
• Jones, S. et al. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum. Mutat. 33, 100–103 (2012).
  Article CAS PubMed Google Scholar
• Guan, B., Wang, T.L. & Shih Ie, M. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res. 71, 6718–6727 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539–542 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Patel, H. et al. SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nat. Genet. 31, 347–348 (2002).
  Article CAS PubMed Google Scholar
• Bakowska, J.C., Jupille, H., Fatheddin, P., Puertollano, R. & Blackstone, C. Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking. Mol. Biol. Cell 18, 1683–1692 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lind, G.E. et al. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene 30, 3967–3978 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Garza-Gonzalez, E. et al. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 7, 70 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Bauer, A.K. et al. Toll-like receptor 4 in butylated hydroxytoluene–induced mouse pulmonary inflammation and tumorigenesis. J. Natl. Cancer Inst. 97, 1778–1781 (2005).
  Article CAS PubMed Google Scholar
• Kennedy, M.N. et al. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J. Biol. Chem. 279, 34698–34704 (2004).
  Article CAS PubMed Google Scholar
• Park, B.S. et al. The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex. Nature 458, 1191–1195 (2009).
  Article CAS PubMed Google Scholar
• Schreiner, A. et al. Junction protein shrew-1 influences cell invasion and interacts with invasion-promoting protein CD147. Mol. Biol. Cell 18, 1272–1281 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, L. et al. Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 483, 608–612 (2012).
  Article CAS PubMed Google Scholar
• Pelletier, N., Champagne, N., Stifani, S. & Yang, X.J. MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. Oncogene 21, 2729–2740 (2002).
  Article CAS PubMed Google Scholar
• Forbes, S.A. et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39, D945–D950 (2011).
  CAS PubMed Google Scholar
• Garnett, M.J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570–575 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Eden, E., Navon, R., Steinfeld, I., Lipson, D. & Yakhini, Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10, 48 (2009).
  Article PubMed PubMed Central Google Scholar
• Eden, E., Lipson, D., Yogev, S. & Yakhini, Z. Discovering motifs in ranked lists of DNA sequences. PLoS Comput. Biol. 3, e39 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Smith, G. et al. Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours—implications for personalised cancer medicine. Br. J. Cancer 102, 693–703 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Adzhubei, I.A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ikediobi, O.N. et al. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol. Cancer Ther. 5, 2606–2612 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, J.W. et al. ERBB2 kinase domain mutation in the lung squamous cell carcinoma. Cancer Lett. 237, 89–94 (2006).
  Article CAS PubMed Google Scholar
• Lee, J.W. et al. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas. Clin. Cancer Res. 12, 57–61 (2006).
  Article CAS PubMed Google Scholar
• Badreddine, R.J. & Wang, K.K. Barrett esophagus: an update. Nat. Rev. Gastroenterol. Hepatol. 7, 369–378 (2010).
  Article PubMed Google Scholar
• Inoue, M. et al. Induction of chromosomal gene mutations in Escherichia coli by direct incorporation of oxidatively damaged nucleotides. New evaluation method for mutagenesis by damaged DNA precursors in vivo. J. Biol. Chem. 273, 11069–11074 (1998).
  Article CAS PubMed Google Scholar
• MacConaill, L.E. et al. Profiling critical cancer gene mutations in clinical tumor samples. PLoS ONE 4, e7887 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Bang, Y.J. et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376, 687–697 (2010).
  Article CAS PubMed Google Scholar
• Fisher, S. et al. A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol. 12, R1 (2011).
  Article PubMed PubMed Central Google Scholar
• Carter, S.L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413–421 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157–1160 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500–501 (2006).
  Article CAS PubMed Google Scholar
• Cibulskis, K. et al. ContEst: estimating cross-contamination of human samples in next-generation sequencing data. Bioinformatics 27, 2601–2602 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Fujita, P.A. et al. The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 39, D876–D882 (2011).
  Article CAS PubMed Google Scholar
• Kozomara, A. & Griffiths-Jones, S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39, D152–D157 (2011).
  CAS PubMed Google Scholar
• Sherry, S.T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308–311 (2001).
  CAS PubMed PubMed Central Google Scholar
• Griffith, O.L. et al. ORegAnno: an open-access community-driven resource for regulatory annotation. Nucleic Acids Res. 36, D107–D113 (2008).
  Article CAS PubMed Google Scholar
• UniProt Consortium. Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 39, D214–D219 (2011).
• Chen, C.L. et al. Impact of replication timing on non-CpG and CpG substitution rates in mammalian genomes. Genome Res. 20, 447–457 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Stamatoyannopoulos, J.A. et al. Human mutation rate associated with DNA replication timing. Nat. Genet. 41, 393–395 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lieberman-Aiden, E. et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326, 289–293 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bolstad, B.M., Irizarry, R.A., Astrand, M. & Speed, T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185–193 (2003).
  Article CAS PubMed Google Scholar